Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Murphy

Showing results (91-100 of 148) with videos related to

Pageof 15
Sort By:
Journal of Virology|July 11, 2000
CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptorS Lee, H L Tiffany, L King, et al.
FEBS Letters|August 31, 1987
Detection of multiple forms of Gi alpha in HL60 cellsP M Murphy, B Eide, P Goldsmith, et al.
The Journal of Biological Chemistry|September 3, 1998
Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1C Combadiere, K Salzwedel, E D Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPRT S Liang, J L Gao, O Fatemi, et al.
Nature Immunology|July 31, 2001
CX3C chemokine mimicry by respiratory syncytial virus G glycoproteinR A Tripp, L P Jones, L M Haynes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1Y Le, H Yazawa, W Gong, et al.
Lancet (London, England)|September 22, 1998
CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)D H McDermott, P A Zimmerman, F Guignard, et al.
Genes and Immunity|October 19, 2001
Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1RA Sahagun-Ruiz, J S Colla, J Juhn, et al.
Biochemical and Biophysical Research Communications|June 22, 2000
The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptorJ K Hartt, T Liang, A Sahagun-Ruiz, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 3, 1999
Inhaled nitric oxide does not alter pulmonary or cardiac effects of fat embolism in dogs after cemented arthroplastyR J Byrick, J B Mullen, P M Murphy, et al.
Pageof 15

Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Journal of Virology|July 11, 2000
CCR8 on human thymocytes functions as a human immunodeficiency virus type 1 coreceptorS Lee, H L Tiffany, L King, et al.
FEBS Letters|August 31, 1987
Detection of multiple forms of Gi alpha in HL60 cellsP M Murphy, B Eide, P Goldsmith, et al.
The Journal of Biological Chemistry|September 3, 1998
Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1C Combadiere, K Salzwedel, E D Smith, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2001
The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPRT S Liang, J L Gao, O Fatemi, et al.
Nature Immunology|July 31, 2001
CX3C chemokine mimicry by respiratory syncytial virus G glycoproteinR A Tripp, L P Jones, L M Haynes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
The neurotoxic prion peptide fragment PrP(106-126) is a chemotactic agonist for the G protein-coupled receptor formyl peptide receptor-like 1Y Le, H Yazawa, W Gong, et al.
Lancet (London, England)|September 22, 1998
CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS)D H McDermott, P A Zimmerman, F Guignard, et al.
Genes and Immunity|October 19, 2001
Contrasting evolution of the human leukocyte N-formylpeptide receptor subtypes FPR and FPRL1RA Sahagun-Ruiz, J S Colla, J Juhn, et al.
Biochemical and Biophysical Research Communications|June 22, 2000
The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptorJ K Hartt, T Liang, A Sahagun-Ruiz, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 3, 1999
Inhaled nitric oxide does not alter pulmonary or cardiac effects of fat embolism in dogs after cemented arthroplastyR J Byrick, J B Mullen, P M Murphy, et al.
Pageof 15